{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:42:34Z","timestamp":1783107754208,"version":"3.54.6"},"reference-count":81,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Integrative Medicine Research"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.imr.2024.101119","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T16:27:34Z","timestamp":1735316854000},"page":"101119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Patient-focused drug development and real-world study"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3431-3721","authenticated-orcid":false,"given":"Haiyin","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4038-817X","authenticated-orcid":false,"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7273-9600","authenticated-orcid":false,"given":"Lin","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6325-0144","authenticated-orcid":false,"given":"Menglong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2277-355X","authenticated-orcid":false,"given":"Xiaolei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8229-5994","authenticated-orcid":false,"given":"Chenyao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6883-3891","authenticated-orcid":false,"given":"Mei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9749-5676","authenticated-orcid":false,"given":"Shigang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2724-338X","authenticated-orcid":false,"given":"Kai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4043-1967","authenticated-orcid":false,"given":"Junhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7701-3964","authenticated-orcid":false,"given":"Zhaochen","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.imr.2024.101119_bib0001","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/14737167.2020.1734454","article-title":"The evolution of patient-focused drug development and Duchenne muscular dystrophy","volume":"20","author":"Crossnohere","year":"2020","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"11","key":"10.1016\/j.imr.2024.101119_bib0002","first-page":"162","article-title":"The value of \u201cpatient-centered\u201d TCM characteristic advantage in ward nursing management","volume":"31","author":"Ruihua","year":"2023","journal-title":"J Tradit Chin Med"},{"issue":"9","key":"10.1016\/j.imr.2024.101119_bib0003","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1177\/1049732320913855","article-title":"Minding the Gap Between the Policy and Practice of Patient-Centeredness: Cocreating a Model for Tensional Dialogue in the \u201cActive Patient Support\u201d Program","volume":"30","author":"Phillips","year":"2020","journal-title":"Qual Health Res"},{"issue":"10","key":"10.1016\/j.imr.2024.101119_bib0004","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/pds.4932","article-title":"Trial designs using real-world data: the changing landscape of the regulatory approval process","volume":"29","author":"Baumfeld","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"12","key":"10.1016\/j.imr.2024.101119_bib0005","first-page":"3101","article-title":"Real world study","volume":"14","author":"Junhua","year":"2019","journal-title":"World Chinese Med"},{"key":"10.1016\/j.imr.2024.101119_bib0006","series-title":"Patient-centered Throughout the Whole Cycle of Drug Research","first-page":"2","author":"Xin","year":"2023"},{"issue":"13","key":"10.1016\/j.imr.2024.101119_bib0007","first-page":"1757","article-title":"Benefit-risk assessment in drugs evaluation","volume":"37","author":"Shuning","year":"2021","journal-title":"Chin J Clin Pharmacol"},{"issue":"04","key":"10.1016\/j.imr.2024.101119_bib0008","first-page":"44","article-title":"Patient-Focused Drug Development: an Important Supplement to the Existing Drug Evaluation System","author":"Xinyu","year":"2021","journal-title":"China Food Drug Adminis Mag"},{"key":"10.1016\/j.imr.2024.101119_bib0009","unstructured":"FDA. Food and Drug Administration Safety and Innovation Act; 2012. Available from: https:\/\/www.fda.gov\/regulatory-information\/selected-amendments-fdc-act\/food-and-drug-administration-safety-and-innovation-act-fdasia. Accessed April 19, 2023."},{"key":"10.1016\/j.imr.2024.101119_bib0010","unstructured":"FDA. PDUFA Reauthorization Performance Goals and Procedures Fiscal Years 2013-2017; 2013. Available from: http:\/\/www.fda.gov\/downloads\/forindustry\/userfees\/prescriptiondruguserfee\/ucm270412. Accessed April 19, 2023."},{"issue":"1","key":"10.1016\/j.imr.2024.101119_bib0011","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/MLR.0000000000000273","article-title":"Patient-Focused Drug Development: a New Direction for Collaboration","volume":"53","author":"Perfetto","year":"2015","journal-title":"Med Care"},{"key":"10.1016\/j.imr.2024.101119_bib0012","unstructured":"FDA. CDER Patient-Focused Drug Development; 2022. Available from: https:\/\/www.fda.gov\/drugs\/Development-approval-process-drugs\/cder-patient-focused-drug-development. Accessed August 18, 2023."},{"key":"10.1016\/j.imr.2024.101119_bib0013","unstructured":"FDA. Plan for Issuance of Patient Focused Drug Development Guidance; 2017. Available from: https:\/\/www.fda.gov\/media\/105979\/download. Accessed April 19, 2023."},{"key":"10.1016\/j.imr.2024.101119_bib0014","unstructured":"FDA. Patient-Focused Drug Development: Incorporating Clinical Outcome Assessments Into Endpoints for Regulatory Decision-Making; 2023. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/patient-focused-drug-development-incorporating-clinical-outcome-assessments-endpoints-regulatory. Accessed April 19, 2023."},{"key":"10.1016\/j.imr.2024.101119_bib0015","unstructured":"FDA. Patient-Focused Drug Development: Methods to identify what is important to patients guidance for industry, Food and Drug Administration staff, and other stakeholders; 2022. Available from: https:\/\/www.fda.gov\/media\/131230\/download. Accessed April 19, 2023."},{"key":"10.1016\/j.imr.2024.101119_bib0016","unstructured":"FDA. Patient-focused drug development: Collecting comprehensive and representative input guidance for industry, Food and Drug Administration staff, and other stakeholders; 2020. Available from: https:\/\/www.fda.gov\/media\/113653\/download. Accessed April 19, 2023."},{"key":"10.1016\/j.imr.2024.101119_bib0017","unstructured":"FDA. Methods to identify what is important to patients & select, develop or modify fit-for-purpose clinical outcomes assessments; 2018. Available from: https:\/\/www.fda.gov\/media\/116277\/download. Accessed August 18, 2023."},{"key":"10.1016\/j.imr.2024.101119_bib0018","unstructured":"Center for Drug Evaluation, NMPA. Technical Guidelines for Patient-centered Benefit-Risk Assessment in Clinical Trials (Draft for Comment); 2022. Available from: https:\/\/www.cde.org.cn\/main\/news\/viewInfoCommon\/fc162e0cda62ebf42754ee90a98035dd. Accessed April 20, 2023."},{"key":"10.1016\/j.imr.2024.101119_bib0019","unstructured":"Center for Drug Evaluation, NMPA. Technical Guidelines for Patient-centered Clinical Trial Design (Draft for Comment); 2022. Available from: https:\/\/www.cde.org.cn\/main\/news\/viewInfoCommon\/0cccaa1f5aeb73dcebf7d4d3e3e88b1c. Accessed April 20, 2023."},{"key":"10.1016\/j.imr.2024.101119_bib0020","unstructured":"Center for Drug Evaluation, NMPA. Technical Guidelines for the Implementation of Patient-centered Clinical Trials (Draft for Comment); 2022. Available from: https:\/\/www.cde.org.cn\/main\/news\/viewInfoCommon\/47f15561b3121091d100e6146fc5249a. Accessed April 20, 2023."},{"issue":"04","key":"10.1016\/j.imr.2024.101119_bib0021","first-page":"439","article-title":"A patient-centered methodological framework for selecting and evaluating traditional Chinese medicine for preventing and treating chronic diseases","volume":"23","author":"Jinbo","year":"2023","journal-title":"Chinese J Evidence-Based Med"},{"issue":"13","key":"10.1016\/j.imr.2024.101119_bib0022","first-page":"3889","article-title":"Consideration and practice on pharmaceutical research and evaluation of\u201cpatient-focused\u201dnew traditional Chinese medicine","volume":"53","author":"Yuehua","year":"2022","journal-title":"Chinese Trad Herbal Dru"},{"issue":"04","key":"10.1016\/j.imr.2024.101119_bib0023","first-page":"1798","article-title":"Problems and strategies in the field of traditional Chinese medicine real world study","volume":"36","author":"Dongmei","year":"2021","journal-title":"Chinese J Tradit Chinese Med"},{"key":"10.1016\/j.imr.2024.101119_bib0024","unstructured":"National Medical Products Administration. NMPA Issued the Announcement on the Guidelines for Real-World Evidence to Support Drug Development and Review (Interim); 2020. Available from: http:\/\/english.nmpa.gov.cn\/2020-01\/07\/c_448382.htm. Accessed April 20, 2023."},{"issue":"23","key":"10.1016\/j.imr.2024.101119_bib0025","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMsb1609216","article-title":"Real-World Evidence-What is It and What Can It Tell Us?","volume":"375","author":"Sherman","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.imr.2024.101119_bib0026","unstructured":"Center for Drug Evaluation, NMPA. Notice on soliciting comments on the Technical Guidelines for the Use of Real-world Data for Clinical Evaluation of Medical Devices (Draft for Soliciting Comments); 2019. Available from: https:\/\/www.cmde.org.cn\/\/zhuanti\/zqyj\/20191213150200919.html. Accessed May 15, 2023."},{"key":"10.1016\/j.imr.2024.101119_bib0027","unstructured":"National Medical Products Administration. Circular on the Publication of Guidelines on Real-world Evidence to Support Drug Development and Review (Trial); 2020. Available from: https:\/\/www.nmpa.gov.cn\/xxgk\/ggtg\/qtggtg\/20200107151901190.html. Accessed May 15, 2023."},{"issue":"05","key":"10.1016\/j.imr.2024.101119_bib0028","first-page":"595","article-title":"Real-world Patient Registry Study in Chinese Medicine: a Review","volume":"17","author":"Liyun","year":"2022","journal-title":"World Chinese Med"},{"issue":"11","key":"10.1016\/j.imr.2024.101119_bib0029","first-page":"1216","article-title":"Analysis of real world studies on traditional Chinese medicine in China","volume":"18","author":"Ji","year":"2018","journal-title":"Chinese J Evid Bas Med"},{"issue":"3","key":"10.1016\/j.imr.2024.101119_bib0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11912-020-0890-3","article-title":"Integration of patient reported outcomes in drug development in genitourinary Cancers","volume":"22","author":"Wong","year":"2020","journal-title":"Curr Oncol Rep"},{"issue":"09","key":"10.1016\/j.imr.2024.101119_bib0031","first-page":"840","article-title":"Application exploration of comparative effectiveness research in clinical efficacy optimization of abdominal acupuncture","volume":"33","author":"Wenbin","year":"2013","journal-title":"Chinese Acupun Moxib"},{"issue":"01","key":"10.1016\/j.imr.2024.101119_bib0032","first-page":"1","article-title":"Chinese practice algorithm on real world study of clinical medicine","volume":"43","author":"Jun","year":"2018","journal-title":"Med J Chin PLA"},{"issue":"03","key":"10.1016\/j.imr.2024.101119_bib0033","first-page":"293","article-title":"Technical specifications for Real world research of TCM: Evidence quality evaluation and report","volume":"63","year":"2022","journal-title":"J Tradit Chin Med"},{"issue":"09","key":"10.1016\/j.imr.2024.101119_bib0034","first-page":"993","article-title":"Formulate technical guidance for real-world studies of traditional Chinese medicine in China to promote the transformation of clinical research of Chinese patent medicine into decision evidence","volume":"20","author":"Xin","year":"2020","journal-title":"Chinese J Evid Based Med"},{"issue":"5","key":"10.1016\/j.imr.2024.101119_bib0035","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s11136-018-1798-3","article-title":"COSMIN guideline for systematic reviews of patient-reported outcome measures","volume":"27","author":"Prinsen","year":"2018","journal-title":"Qual Life Res"},{"issue":"11","key":"10.1016\/j.imr.2024.101119_bib0036","doi-asserted-by":"crossref","first-page":"e30042","DOI":"10.2196\/30042","article-title":"Use of patient-reported outcome measures and patient-reported experience measures within evaluation studies of telemedicine applications: systematic review","volume":"23","author":"Knapp","year":"2021","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.imr.2024.101119_bib0037","unstructured":"FDA. Patient-focused drug development glossary; 2022. Available from: https:\/\/www.fda.gov\/drugs\/development-approval-process-drugs\/patient-focused-drug-development-glossary. Accessed April 19, 2023."},{"issue":"4","key":"10.1016\/j.imr.2024.101119_bib0038","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s40271-014-0065-0","article-title":"A systematic review of the impact of patient and public involvement on service users, researchers and communities","volume":"7","author":"Brett","year":"2014","journal-title":"Patient"},{"issue":"19","key":"10.1016\/j.imr.2024.101119_bib0039","first-page":"2312","article-title":"Promoting patient involvement in medicine R&D in European Union and its implications for China","volume":"28","author":"Yuxia","year":"2019","journal-title":"Chinese J New Drugs"},{"issue":"3","key":"10.1016\/j.imr.2024.101119_bib0040","doi-asserted-by":"crossref","first-page":"203","DOI":"10.7326\/0003-4819-151-3-200908040-00125","article-title":"Comparative effectiveness research: a report from the Institute of Medicine","volume":"151","author":"Sox","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.imr.2024.101119_bib0041","article-title":"More stakeholder engagement is needed to improve quality of research, say US experts","volume":"341","author":"Bob","year":"2010","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.imr.2024.101119_bib0042","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.107.690917","article-title":"Outcomes research: generating evidence for best practice and policies","volume":"118","author":"Krumholz","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.imr.2024.101119_bib0043","series-title":"Real World Research 3rd Edn","author":"Robson","year":"2011"},{"issue":"12","key":"10.1016\/j.imr.2024.101119_bib0044","first-page":"3127","article-title":"Analysis of real world study of traditional chinese medicine based on chinese clinical trial registry","volume":"14","author":"Hui","year":"2019","journal-title":"World Chinese Med"},{"issue":"10","key":"10.1016\/j.imr.2024.101119_bib0045","first-page":"1339","article-title":"Intention-to-treat principle","volume":"165","author":"Montori","year":"2001","journal-title":"Cmaj"},{"issue":"01","key":"10.1016\/j.imr.2024.101119_bib0046","first-page":"117","article-title":"Statistical methods in pragmatic randomized controlled trials (I): addressing noncompliance","volume":"21","author":"Qingyang","year":"2021","journal-title":"Chinese J Evid Based Med"},{"issue":"14","key":"10.1016\/j.imr.2024.101119_bib0047","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1056\/NEJMsm1605385","article-title":"Per-protocol analyses of pragmatic trials","volume":"377","author":"Hernan","year":"2017","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.imr.2024.101119_bib0048","article-title":"The intention-to-treat analysis is not always the conservative approach","volume":"130","author":"Ian","year":"2017","journal-title":"Am J Med"},{"issue":"07","key":"10.1016\/j.imr.2024.101119_bib0049","first-page":"787","article-title":"Technical guidance for statistical analysis to assess therapeutic outcomes using realworld data","volume":"19","author":"Pei","year":"2019","journal-title":"Chinese J Evid Based Med"},{"issue":"5","key":"10.1016\/j.imr.2024.101119_bib0050","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/hex.12090","article-title":"Patient and service user engagement in research: a systematic review and synthesized framework","volume":"18","author":"Shippee","year":"2015","journal-title":"Health Expect"},{"key":"10.1016\/j.imr.2024.101119_bib0051","unstructured":"Patient-Centered Outcomes Research Institute. The PCORI Methodology Report; 2021. Available from: https:\/\/www.pcori.org\/sites\/default\/files\/PCORI-Methodology-Report.pdf. Accessed April 1, 2024."},{"issue":"1","key":"10.1016\/j.imr.2024.101119_bib0052","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11606-015-3450-z","article-title":"Patient and Stakeholder Engagement in the PCORI Pilot Projects: Description and Lessons Learned","volume":"31","author":"Forsythe","year":"2016","journal-title":"J Gen Intern Med"},{"issue":"8","key":"10.1016\/j.imr.2024.101119_bib0053","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1524-4733.2009.00600.x","volume":"12","author":"Berger","year":"2009","journal-title":"Value Health"},{"issue":"11","key":"10.1016\/j.imr.2024.101119_bib0054","first-page":"1198","article-title":"Ethical review of real world studies","volume":"18","author":"Hong","year":"2018","journal-title":"Chinese J Evid Based Med"},{"issue":"07","key":"10.1016\/j.imr.2024.101119_bib0055","first-page":"755","article-title":"Developing technical guidance for real-world data and studies to achieve better production and use of real-world evidence in China","volume":"19","author":"Xin","year":"2019","journal-title":"Chinese J Evid Based Med"},{"issue":"13","key":"10.1016\/j.imr.2024.101119_bib0056","first-page":"1356","article-title":"Discussion on the status and development trends of patient centered clinical trials","volume":"33","author":"Zhongjian","year":"2024","journal-title":"Chinese J New Drugs"},{"issue":"2","key":"10.1016\/j.imr.2024.101119_bib0057","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s40271-020-00479-8","article-title":"Engaging patients in real-world evidence: an atrial fibrillation patient advisory board case example","volume":"14","author":"Oehrlein","year":"2021","journal-title":"Patient"},{"issue":"4","key":"10.1016\/j.imr.2024.101119_bib0058","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s40271-019-00356-z","article-title":"Patient-community perspectives on real-world evidence: enhancing engagement, understanding, and trust","volume":"12","author":"Oehrlein","year":"2019","journal-title":"Patient"},{"issue":"1","key":"10.1016\/j.imr.2024.101119_bib0059","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/cpt.1465","article-title":"The missing reality of real life in real-world evidence","volume":"106","author":"Okun","year":"2019","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.imr.2024.101119_bib0060","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/jamia\/ocv191","article-title":"Harnessing person-generated health data to accelerate patient-centered outcomes research: the crohn's and colitis foundation of america pcornet patient powered research network (CCFA Partners)","volume":"23","author":"Chung","year":"2016","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.imr.2024.101119_bib0061","article-title":"Current status of implementation of patient involvement in health care to improve quality of care among chronic obstructive pulmonary disease:a scoping review","author":"Hongling","year":"2024","journal-title":"Chinese Gener Prac"},{"issue":"20","key":"10.1016\/j.imr.2024.101119_bib0062","first-page":"78","article-title":"Public and patient involvement in uk medical research","volume":"41","author":"Ping","year":"2020","journal-title":"Med Philos"},{"issue":"2","key":"10.1016\/j.imr.2024.101119_bib0063","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2217\/cer.12.7","article-title":"Stakeholder participation in comparative effectiveness research: defining a framework for effective engagement","volume":"1","author":"Deverka","year":"2012","journal-title":"J Comp Eff Res"},{"key":"10.1016\/j.imr.2024.101119_bib0064","unstructured":"Patient-Centered Outcomes Research Institute. Patient centered outcomes research institute (PCORI) Strategic Plan; 2022. Available from: https:\/\/www.pcori.org\/about\/about-pcori\/pcori-strategic-plan. Accessed September 29, 2022."},{"key":"10.1016\/j.imr.2024.101119_bib0065","unstructured":"Center for Drug Evaluation, NMPA. Notice on soliciting comments on the technical guidelines for patient-centered clinical trial design (draft for Comment); 2022. Available from: https:\/\/www.cde.org.cn\/main\/news\/viewInfoCommon\/0cccaa1f5aeb73dcebf7d4d3e3e88b1c. Accessed April 19, 2023."},{"issue":"3","key":"10.1016\/j.imr.2024.101119_bib0066","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4103\/2229-3485.159936","article-title":"Patient centric approach for clinical trials: Current trend and new opportunities","volume":"6","author":"Sharma","year":"2015","journal-title":"Perspect Clin Res"},{"key":"10.1016\/j.imr.2024.101119_bib0067","unstructured":"Center for Drug Evaluation, NMPA. Key considerations in using real-world evidence to support drug development (draft for public review); 2019. Available from: https:\/\/www.cde.org.cn\/main\/news\/viewInfoCommon\/7e6fb9fc3f066a966a02130f24dbff1c. Accessed April 20, 2023."},{"issue":"02","key":"10.1016\/j.imr.2024.101119_bib0068","first-page":"139","article-title":"Effect on research and clinical research of traditional chinese medicine","volume":"19","author":"Yanmin","year":"2013","journal-title":"Chinese J Basic Med Trad Chinese Med"},{"key":"10.1016\/j.imr.2024.101119_bib0069","unstructured":"Patient-Centered Outcomes Research Institute. Patient-centered outcomes research; 2013. Available from: http:\/\/www.pcori.org\/patient-centered-outcomes-research. Accessed April 1, 2024."},{"issue":"6","key":"10.1016\/j.imr.2024.101119_bib0070","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1067\/mje.2001.115577","article-title":"Outcomes research review","volume":"14","author":"Seto","year":"2001","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.imr.2024.101119_bib0071","series-title":"Crossing the Quality Chasm: a New Health System for the 21st Century","year":"2001"},{"issue":"12","key":"10.1016\/j.imr.2024.101119_bib0072","first-page":"1472","article-title":"Introduction of patient-focused drug development related concepts","volume":"23","author":"Xiaolei","year":"2023","journal-title":"Chinese J Evid Based Med"},{"issue":"05","key":"10.1016\/j.imr.2024.101119_bib0073","first-page":"556","article-title":"Challenges of ethical review in patient-centered clinical trials","volume":"37","author":"Zengrui","year":"2024","journal-title":"Chinese Med Ethics"},{"issue":"02","key":"10.1016\/j.imr.2024.101119_bib0074","first-page":"377","article-title":"The advantages and limitations of real-world Chinese medicine research","volume":"21","author":"Song","year":"2023","journal-title":"Chin J Integr Med"},{"issue":"07","key":"10.1016\/j.imr.2024.101119_bib0075","first-page":"1262","article-title":"Overview of real world research on TCM differentiation and treatment of angina pectoris in coronary heart disease","volume":"22","author":"Yanan","year":"2024","journal-title":"Chin J Integr Med"},{"issue":"3","key":"10.1016\/j.imr.2024.101119_bib0076","first-page":"184","article-title":"Traditional Chinese medicine for promoting mental health of patients with COVID-19: a scoping review","volume":"2","author":"Ji","year":"2022","journal-title":"Acupunct Herb Med"},{"issue":"04","key":"10.1016\/j.imr.2024.101119_bib0077","first-page":"383","article-title":"Study on evaluation methods of clinical efficacy of ancient Chinese medicine","volume":"17","author":"Jun","year":"2011","journal-title":"Chinese J Basic Med Traditio Chinese Med"},{"issue":"07","key":"10.1016\/j.imr.2024.101119_bib0078","first-page":"1336","article-title":"Professor Dong Bo's experience in treating chest numbness and heartache from the Five Zang Yang Qi","volume":"22","author":"Qiman","year":"2024","journal-title":"Chinese J Integr Med Cardio-Cerebrovas Dis"},{"issue":"12","key":"10.1016\/j.imr.2024.101119_bib0079","first-page":"3115","article-title":"Application scenarios of real world study in traditional chinese medicine","volume":"14","author":"Bo","year":"2019","journal-title":"World Chinese Med"},{"issue":"08","key":"10.1016\/j.imr.2024.101119_bib0080","first-page":"901","article-title":"Guidelines on clinical research methods of TCM and integrated Traditional Chinese and Western medicine","volume":"35","author":"Dsim","year":"2015","journal-title":"Chin J Integr Med"},{"key":"10.1016\/j.imr.2024.101119_bib0081","unstructured":"Bulbeck H. About priority setting partnerships; 2022. Available from: https:\/\/www.jla.nihr.ac.uk\/about-the-james-lind-alliance\/about-psps.htm. Accessed April 1, 2024."}],"container-title":["Integrative Medicine Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213422024000994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213422024000994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T13:58:24Z","timestamp":1742306304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213422024000994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2213422024000994"],"URL":"https:\/\/doi.org\/10.1016\/j.imr.2024.101119","relation":{},"ISSN":["2213-4220"],"issn-type":[{"value":"2213-4220","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-focused drug development and real-world study","name":"articletitle","label":"Article Title"},{"value":"Integrative Medicine Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imr.2024.101119","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Korea Institute of Oriental Medicine. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101119"}}